Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-04-24
2007-04-24
Andres, Janet L. (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C514S006900, C514S331000
Reexamination Certificate
active
10837762
ABSTRACT:
A method for the improvement of neuronal regeneration by prevention or inhibition of basal membrane formation induced by a lesion of neuronal tissue.
REFERENCES:
patent: 4457936 (1984-07-01), Draeger et al.
patent: 4717727 (1988-01-01), Günzler et al.
patent: 83/04104 (1983-11-01), None
patent: 93/19783 (1993-10-01), None
patent: 94/17831 (1994-08-01), None
patent: WO 94/17831 (1994-08-01), None
patent: 95/10305 (1995-04-01), None
patent: WO 95/10305 (1995-04-01), None
patent: 95/13291 (1995-05-01), None
patent: WO 95/13291 (1995-05-01), None
patent: 96/00582 (1996-01-01), None
Pettit et al. The development of site specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends in Biotech 16: 343-349, 1998.
Hermanns et al. 2,2′-bipyridine but not its dicarboxylic acid derivative fails to prevent collagen scar formation after spinal cord injury in the adult rat. Society for Neurosci Abs 26(1-2): 3236, 2000.
Joosten et al. Collagen IV deposits do not prevent regrowing axons from penetrating the lesion site in spianl cord injury. J Neurosci Res 62: 686-691, 2000.
Stichel et al. Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons. Neurosci 93(1): 321-333, 1999.
Feringa et al. 1980. Basal lamina formation at the site of spinal cord transection. Ann Neurol 8: 148-154.
White and Kraus. 1993. Brain injury and repair machanisms: the potential for pharmacologic therapy in closed-head trauma. Ann Emergency Medicine 22(6): 632-646.
Stichel and Muller. 1995. Regenerative failure in the mammalian CNS. Trends in Neurosciences 18(3): 128-129.
Jackowski. 1995. Neural injury repair: hope for the future as barriers to effective CNS regeneration become clearer. British J. of Neurosurgery 9: 303-317.
Kruczewski et al. 1992. Glial response to transection of the rat postcommissural fornix. European J. Neurosciences S5: 190.
Feringa et al., “Basal Lamina Formation at the Site of Spinal Cord Transection”, Annals of Neurology, vol. 8, (1980), 148-154.
Franklin et al., “Approaches to the design of anti-fibrotic drugs”, Biochemical Society Transactions, vol. 19, (1991).
Cunliffe et al., “Novel Inhibitors of Proly 4-Hydroxylase. 3.1Inhibition by the Substrate Analogy—Oxaloglycine and its Derivatives”, J. Med. Chem., 35, (1992), 2652-2658.
Dowell, Robert I. and Hadley, Elizabeth M., “Novel Inhibitors of Prolyl 4-Hydroxylase”, J. Med. Chem., 35, (1992), 800-804.
Hales, Neil J. and Beattie, John F., “Novel Inhibitors of Prolyl 4-Hydroxylase. 5.1The Intriguing Structure-Activity Relationships Seen with 2,2′-Bipyridine and its 5,5′-Dicarboxylic Acid Derivatives”, J. Med. Chem., 36, (1993), 3853-3858.
Hunt et al., “The Effect of Desferrioxamine on Fibroblasts and Collagen Formation in Cell Cultures,” British Journal of Haematology, 41, (1979), 69-76.
Ishimaru et al., Inhibition of Prolyl Hydroxylase Activity and Collagen Biosynthesis by Fibrostatin C, AS novel Inhibitor Produced byStreptomyces catenulaeSubsp.GriseosporaNo. 23924, The Journal of Antibiotics, vol., XLI, (1988), 1668-1674.
Sasaki et al., Reduction of Collagen Production in Keloid Fibroblast Cultures by Ethyl-3-,4-dihydroxybenzoate, The Journal of Biological Chemistry, 262, (1987), 9397-9403.
Puchala, Elizabeth and Windle, William F., “The Possibility of Structural and Functional Restitution after Spinal Cord Injury. A Review”, Experimental Neurology, 55, (1977), 1-42.
Franklin, Trevor J. and Hitchen, Michael, “Inhibition of collagen hydroxylation by 2,7, 8-trihydroxyanthraquinone in embryonic-chick tendon cells”, Biochem J., 261, (1989), 127-130.
Gunzler et al., “Time-dependent inactivation of chick-embryo prolyl 4-hydroxylase by coumalic acid”, Biochem. J. 242, (1987), 163-169.
Karvonen et al., “Specific Inactivation of Prolyl 4-Hydroxylase and Inhibition of Colleagen Synthesis by by Oxaproline-containing Peptides in Cultured Human Skin Fibroblasts”, The Journal of Biological Chemistry, 265, (1990), 8415-8419.
Einheber et al., “Transforming Growth Factor-β1 Regulates Axon/Schwann Cell Interactions”, The Journal of Cell Biology, 129, (1993), 443-458.
Stichel, C.C. and Muller, H.W., Relationship between injury-induced astrogliosis, laminin expression and axonal sprouting in the adult rat brain, Journal of Neurocytology, 23, (1994), 615-630.
Müller et al., “Astroglial Neurotrophic and neurite-promoting factors,” Pharmacology & Therapeutics, 65, (1995) 1-18.
Müller Hans Werner
Stichel-Gunkel Christine C.
Andres Janet L.
Emch Gregory
Jacobson & Holman PLLC
Neuraxo Biopharmaceuticals GmbH
LandOfFree
Method for the improvement of neuronal regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the improvement of neuronal regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the improvement of neuronal regeneration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3738396